Get started
Author

Amy Custer

Observed names: A. Custer, Custer Amy, Custer, Amy
ORCID: 0000-0002-3572-5138
Observed ORCID: 0000-0002-3572-5138
OpenAlex ID: A5032012412
Clinical Considerations for Routine Auditory and Vestibular Monitoring in Patients With Cystic Fibrosis
2021 · Angela C. Garinis, Gayla L. Poling, et al. · American Journal of Audiology · 23
Audiological Outcomes of Weekly vs. Triweekly Cisplatin in Head and Neck Cancer with Cochlear-Sparing Intensity-Modulated Radiation Therapy
2024 · Mauricio E. Gamez, Dukagjin M. Blakaj, et al. · Cancers · 10
The Relationship Between Self-Perceived Hearing Ability and Binaural Speech-in-Noise Performance in Adults With Normal Pure-Tone Hearing
2021 · Christina M. Roup, Amy Custer, et al. · Perspectives of the ASHA Special Interest Groups · 5
Incidence of ototoxicity in head and neck cancer (HNSCC) patients (pts) receiving concomitant chemo-radiation (CRT) with weekly or triweekly cisplatin (Cis).
2018 · Jishu Das, Amy Custer, et al. · Journal of Clinical Oncology · 2
A Tale of Two Susceptibilities: Cisplatin Ototoxicity Variability in Similar Patients
2022 · Amy Custer · Perspectives of the ASHA Special Interest Groups
Ototoxicity management and cystic fibrosis (Garinis et al., 2021)
2021 · Garinis Angela C., Poling Gayla L., et al. · Nottingham ePrints (University of Nottingham)
Not So Fast: Geriatric Syndromes Can Be Identified and Intervened upon Prior to Allogeneic Stem Cell Transplantation
2020 · Sarah A Wall, Ying Huang, et al. · Transplantation and Cellular Therapy
Embedded Ear Care: Audiology on the Cancer Treatment Team
2019 · Amy Custer · ASHA Leader
PDF
A Prospective Analysis of Ototoxicity in Modern Radiation Therapy Treatments for Head and Neck Squamous Cell Carcinoma (HNSCC) Patients Receiving Concomitant Chemo-Radiation (CRT) with Weekly or Tri-weekly Cisplatin (Cis)
2018 · D.M. Blakaj, A. Custer, et al. · International Journal of Radiation Oncology*Biology*Physics
Works count: 10
Citation count: 40
H-index: 3
I10-index: 2
Year
Topic
Type